7 photos

• Sort by: number of views (most to least) number of views (least to most) number of comments (most to least) number of comments (least to most) number of favorites (most to least) number of favorites (least to most) date uploaded (newest first) date uploaded (oldest first) random

• Figure 5: Decrease in FDA First Cycle Review Time for Abbreviated New Drug Applications, Fiscal Years 2013 through 2015

  • Uploaded by: U.S. Government Accountability Office
  • License: United States Government Work
  • 0 comments
  • 0 favorites
  • 3,303 views
  • Date uploaded: 2017-06-27
  • Tags: gao, governmentaccountabilityoffice, usgovernmentaccountabilityoffice, usgao, unitedstatesgovernmentaccountabilityoffice, government, congress, watchdog, oversight, governmentwatchdog, gao17452, genericdruguserfees, anda, abbreviatednewdrugapplication, cber, centerforbiologicsevaluationandresearch, cder, centerfordrugevaluationandresearch, fda, foodanddrugadministration, fy, fiscalyear, gdufa, genericdruguserfeeamendmentsof2012, hhs, departmentofhealthandhumanservices, hq, headquarters, it, informationtechnology, ogd, officeofgenericdrugs, ora, officeofregulatoryaffairs, pas, priorapprovalsupplement
  • Visibility: public
• Figure 6: Decrease in FDA First Cycle Review Time for Prior Approval Supplements, Fiscal Years 2013 through 2015

  • Uploaded by: U.S. Government Accountability Office
  • License: United States Government Work
  • 0 comments
  • 0 favorites
  • 3,197 views
  • Date uploaded: 2017-06-27
  • Tags: gao, governmentaccountabilityoffice, usgovernmentaccountabilityoffice, usgao, unitedstatesgovernmentaccountabilityoffice, government, congress, watchdog, oversight, governmentwatchdog, gao17452, genericdruguserfees, anda, abbreviatednewdrugapplication, cber, centerforbiologicsevaluationandresearch, cder, centerfordrugevaluationandresearch, fda, foodanddrugadministration, fy, fiscalyear, gdufa, genericdruguserfeeamendmentsof2012, hhs, departmentofhealthandhumanservices, hq, headquarters, it, informationtechnology, ogd, officeofgenericdrugs, ora, officeofregulatoryaffairs, pas, priorapprovalsupplement
  • Visibility: public
• Figure 1: Food and Drug Administration (FDA) Centers and Offices with Targeted Regulatory Science Projects Related to Medical Products, as of February 2016

  • Uploaded by: U.S. Government Accountability Office
  • License: United States Government Work
  • 0 comments
  • 0 favorites
  • 2,022 views
  • Date uploaded: 2016-07-01
  • Tags: gao, governmentaccountabilityoffice, usgovernmentaccountabilityoffice, usgao, unitedstatesgovernmentaccountabilityoffice, government, congress, watchdog, oversight, governmentwatchdog, gao16432, medicalproductoversight, cber, centerforbiologicsevaluationandresearch, cder, centerfordrugevaluationandresearch, cdrh, centerfordevicesandradiologicalhealth, fda, foodanddrugadministration, fdasia, foodanddrugadministrationsafetyandinnovationactof2012, gdufa, genericdruguserfeeamendmentsof2012, gpra, governmentperformanceandresultsactof1993, hhs, departmentofhealthandhumanservices, nctr, nationalcenterfortoxicologicalresearch, ocet, officeofcounterterrorismandemergingthreats, oip, officeofinternationalprograms, omh, officeofminorityhealth, orsi, officeofregulatoryscienceandinnovation, owh, officeofwomenshealth, pdufa, prescriptiondruguserfeeact
  • Visibility: public
• Figure 2: Total Number of Food and Drug Administration (FDA) Medical Product Center Employees, Fiscal Years 2012 to 2015

  • Uploaded by: U.S. Government Accountability Office
  • License: United States Government Work
  • 1 comment
  • 0 favorites
  • 2,010 views
  • Date uploaded: 2016-07-01
  • Tags: gao, governmentaccountabilityoffice, usgovernmentaccountabilityoffice, usgao, unitedstatesgovernmentaccountabilityoffice, government, congress, watchdog, oversight, governmentwatchdog, gao16500, foodanddrugadministration, bsufa, biosimilaruserfeeact, cber, centerforbiologicsevaluationandresearch, cder, centerfordrugevaluationandresearch, cdrh, centerfordevicesandradiologicalhealth, fda, fdasia, foodanddrugadministrationsafetyandinnovationactof2012, gdufa, genericdruguserfeeamendmentsact, gpra, governmentperformanceandresultsactof1993, hhs, departmentofhealthandhumanservices, mdufa, medicaldeviceuserfeeandmodernizationact, pdufa, prescriptiondruguserfeeactof1992, simp, strategicintegratedmanagementplan
  • Visibility: public
• Figure 1: Key Interactions and Stakeholders Involved in the Distribution of and Payment for Generic Drugs

  • Uploaded by: U.S. Government Accountability Office
  • License: United States Government Work
  • 0 comments
  • 0 favorites
  • 1,796 views
  • Date uploaded: 2016-09-22
  • Tags: gao, governmentaccountabilityoffice, usgovernmentaccountabilityoffice, usgao, unitedstatesgovernmentaccountabilityoffice, government, congress, watchdog, oversight, governmentwatchdog, gao16706, genericdrugsundermedicare, anda, abbreviatednewdrugapplication, api, activepharmaceuticalingredient, cms, centersformedicaremedicaidservices, fda, foodanddrugadministration, ftc, federaltradecommission, gdufa, genericdruguserfeeamendmentsof2012, hhs, departmentofhealthandhumanservices, pbm, pharmacybenefitmanager, pde, prescriptiondrugevent
  • Visibility: public
• Figure 2: Price Trends under Medicare Part D for the Changing Basket and Established Basket of Generic Drugs, First Quarter 2010 through the Second Quarter 2015

  • Uploaded by: U.S. Government Accountability Office
  • License: United States Government Work
  • 0 comments
  • 0 favorites
  • 1,748 views
  • Date uploaded: 2016-09-22
  • Tags: gao, governmentaccountabilityoffice, usgovernmentaccountabilityoffice, usgao, unitedstatesgovernmentaccountabilityoffice, government, congress, watchdog, oversight, governmentwatchdog, gao16706, genericdrugsundermedicare, anda, abbreviatednewdrugapplication, api, activepharmaceuticalingredient, cms, centersformedicaremedicaidservices, fda, foodanddrugadministration, ftc, federaltradecommission, gdufa, genericdruguserfeeamendmentsof2012, hhs, departmentofhealthandhumanservices, pbm, pharmacybenefitmanager, pde, prescriptiondrugevent
  • Visibility: public
• Figure 1: The 10 Countries with the Most Foreign Drug Establishments Manufacturing Drugs for the U.S. Market as of June 2021

  • Uploaded by: U.S. Government Accountability Office
  • License: United States Government Work
  • 0 comments
  • 0 favorites
  • 1,128 views
  • Date uploaded: 2022-02-17
  • Tags: gao, governmentaccountabilityoffice, usgovernmentaccountabilityoffice, usgao, unitedstatesgovernmentaccountabilityoffice, government, congress, watchdog, oversight, governmentwatchdog, drugsafety, gao22103611, api, activepharmaceuticalingredient, cder, centerfordrugevaluationandresearch, cgmp, currentgoodmanufacturingpractices, conops, conceptofoperations, covid19, coronavirusdisease2019, facts, fieldaccomplishmentsandcompliancetrackingsystem, fda, foodanddrugadministration, fdasia, foodanddrugadministrationsafetyandinnovationact, gdufa, genericdruguserfeeact, gs, generalschedule, hhs, departmentofhealthandhumanservices, nai, noactionindicated, oai, officialactionindicated, ogps, officeofglobalpolicyandstrategy, opm, officeofpersonnelmanagement, ora, officeofregulatoryaffairs, vai, voluntaryactionindicated
  • Visibility: public